Sales Support:
sales@worldwidemarketreports.com
U.S. :+1-252-477-1362
U.K. :+44-203-949-5508
AUS. : +61-8-7924-7805
INDIA :+91-848-285-0837
Menu Icon Close Icon
Discount sale is live
Discount sale is live
We have an updated report [Version - 2025] available. Kindly sign up to get the sample of the report.

Rabies Vaccine for Humans Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

  • Report Code : 565383
  • Industry : Medical Devices
  • Published On : Dec 2020
  • Pages : 90
  • Publisher : 99strategy
  • Format: Excel and PDF

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Rabies Vaccine for Humans market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Rabies Vaccine for Humans are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Rabies Vaccine for Humans market segmented into
Preventative Vaccine
Emergency Rabies Vaccine

Based on the end-use, the global Rabies Vaccine for Humans market classified into
Pre-exposure prophylaxis
Post-exposure prophylaxis

Based on geography, the global Rabies Vaccine for Humans market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Novartis
Sanofi
GlaxoSmithKline
Merck
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL RABIES VACCINE FOR HUMANS INDUSTRY
2.1 Summary about Rabies Vaccine for Humans Industry
2.2 Rabies Vaccine for Humans Market Trends
2.2.1 Rabies Vaccine for Humans Production & Consumption Trends
2.2.2 Rabies Vaccine for Humans Demand Structure Trends
2.3 Rabies Vaccine for Humans Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Preventative Vaccine
4.2.2 Emergency Rabies Vaccine
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Pre-exposure prophylaxis
4.3.2 Post-exposure prophylaxis
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Preventative Vaccine
5.2.2 Emergency Rabies Vaccine
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Pre-exposure prophylaxis
5.3.2 Post-exposure prophylaxis
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Preventative Vaccine
6.2.2 Emergency Rabies Vaccine
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Pre-exposure prophylaxis
6.3.2 Post-exposure prophylaxis
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Preventative Vaccine
7.2.2 Emergency Rabies Vaccine
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Pre-exposure prophylaxis
7.3.2 Post-exposure prophylaxis
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Preventative Vaccine
8.2.2 Emergency Rabies Vaccine
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Pre-exposure prophylaxis
8.3.2 Post-exposure prophylaxis
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Preventative Vaccine
9.2.2 Emergency Rabies Vaccine
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Pre-exposure prophylaxis
9.3.2 Post-exposure prophylaxis
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Novartis
10.1.2 Sanofi
10.1.3 GlaxoSmithKline
10.1.4 Merck
10.1.5 Chengda
10.1.6 Yisheng
10.1.7 Prcmise
10.1.8 VACN
10.1.9 Changsheng
10.1.10 BCHT
10.1.11 Hissen
10.2 Rabies Vaccine for Humans Sales Date of Major Players (2017-2020e)
10.2.1 Novartis
10.2.2 Sanofi
10.2.3 GlaxoSmithKline
10.2.4 Merck
10.2.5 Chengda
10.2.6 Yisheng
10.2.7 Prcmise
10.2.8 VACN
10.2.9 Changsheng
10.2.10 BCHT
10.2.11 Hissen
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Table
Table Rabies Vaccine for Humans Product Type Overview
Table Rabies Vaccine for Humans Product Type Market Share List
Table Rabies Vaccine for Humans Product Type of Major Players
Table Brief Introduction of Novartis
Table Brief Introduction of Sanofi
Table Brief Introduction of GlaxoSmithKline
Table Brief Introduction of Merck
Table Brief Introduction of Chengda
Table Brief Introduction of Yisheng
Table Brief Introduction of Prcmise
Table Brief Introduction of VACN
Table Brief Introduction of Changsheng
Table Brief Introduction of BCHT
Table Brief Introduction of Hissen
Table Products & Services of Novartis
Table Products & Services of Sanofi
Table Products & Services of GlaxoSmithKline
Table Products & Services of Merck
Table Products & Services of Chengda
Table Products & Services of Yisheng
Table Products & Services of Prcmise
Table Products & Services of VACN
Table Products & Services of Changsheng
Table Products & Services of BCHT
Table Products & Services of Hissen
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Rabies Vaccine for Humans Market Forecast (Million USD) by Region 2021f-2026f
Table Global Rabies Vaccine for Humans Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Rabies Vaccine for Humans Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Rabies Vaccine for Humans Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure
Figure Global Rabies Vaccine for Humans Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Rabies Vaccine for Humans Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Rabies Vaccine for Humans Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Rabies Vaccine for Humans Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Rabies Vaccine for Humans Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Rabies Vaccine for Humans Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Rabies Vaccine for Humans Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Preventative Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Emergency Rabies Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pre-exposure prophylaxis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Post-exposure prophylaxis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Preventative Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Emergency Rabies Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pre-exposure prophylaxis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Post-exposure prophylaxis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Preventative Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Emergency Rabies Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pre-exposure prophylaxis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Post-exposure prophylaxis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Preventative Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Emergency Rabies Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pre-exposure prophylaxis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Post-exposure prophylaxis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Preventative Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Emergency Rabies Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pre-exposure prophylaxis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Post-exposure prophylaxis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Preventative Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Emergency Rabies Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pre-exposure prophylaxis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Post-exposure prophylaxis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rabies Vaccine for Humans Sales Revenue (Million USD) of Novartis 2017-2020e
Figure Rabies Vaccine for Humans Sales Revenue (Million USD) of Sanofi 2017-2020e
Figure Rabies Vaccine for Humans Sales Revenue (Million USD) of GlaxoSmithKline 2017-2020e
Figure Rabies Vaccine for Humans Sales Revenue (Million USD) of Merck 2017-2020e
Figure Rabies Vaccine for Humans Sales Revenue (Million USD) of Chengda 2017-2020e
Figure Rabies Vaccine for Humans Sales Revenue (Million USD) of Yisheng 2017-2020e
Figure Rabies Vaccine for Humans Sales Revenue (Million USD) of Prcmise 2017-2020e
Figure Rabies Vaccine for Humans Sales Revenue (Million USD) of VACN 2017-2020e
Figure Rabies Vaccine for Humans Sales Revenue (Million USD) of Changsheng 2017-2020e
Figure Rabies Vaccine for Humans Sales Revenue (Million USD) of BCHT 2017-2020e
Figure Rabies Vaccine for Humans Sales Revenue (Million USD) of Hissen 2017-2020e

Happy To Assist You

We are happy to help! Call or write to us

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides an industry forecast. The market was valued at US$ xxx million in 2025, and is expected to grow at a CAGR of xx% during the period 2025–2032.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
  • Types
  • Applications
  • Technology
  • End-use Industries
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers and restraints
  • Regulatory scenario
  • Industry trend
  • Pestle analysis
  • Porter’s analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Competitive landscape
It helps the businesses in making strategic decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

sales@worldwidemarketreports.com

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Var Worldwide Market Reports Pvt Ltd, 402, Bremen Business Center, University Road, Pune-411007,India.

phoneiconU.S. : +1-252-477-1362

phoneiconU.K. :+44-203-949-5508

phoneiconAUS. :+61-8-7924-7805

phoneiconIndia :+91-848-285-0837

Menu
Quick Links
Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By
paymenticon
Connect Us
© 2025 Worldwide Market Reports. All Rights Reserved